Huayu Pharmaceuticals: The company passed the on-site inspection of the US FDA.

Huayu Pharmaceuticals announcement that the company accepted the current Good Manufacturing Practice (cGMP) inspection and pre-approval inspection from the U.S. Food and Drug Administration from October 27, 2025, to November 6, 2025. Recently, the company received an on-site inspection report issued by the FDA, which indicated that the FDA confirmed that the inspection had been completed and the company passed the cGMP inspection and pre-approval inspection.